Related Experiment Video

Updated: May 25, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

The relationship between pneumococcal serotypes and antibiotic resistance

Jae-Hoon Song1, Ron Dagan, Keith P Klugman

  • 1Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong Gangnam-gu, Seoul, Republic of Korea. songjh@skku.edu

Vaccine
|February 15, 2012
PubMed

Insights

Antibiotic-resistant Streptococcus pneumoniae (SP) serotypes are a growing global concern. This study examines trends in SP antibiotic resistance and serotype distribution over the past decade, highlighting the need for vaccination and surveillance.

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Background:

  • Streptococcus pneumoniae (SP) causes significant disease burden globally.
  • SP exhibits over 93 serotypes, varying in disease potential and antibiotic resistance.
  • Increasing global prevalence of antibiotic-resistant SP serotypes is a major public health challenge.

Purpose of the Study:

  • To investigate the relationship between antibiotic resistance and SP serotypes.
  • To analyze trends in antibiotic resistance and serotype distribution over the last 10 years.
  • To evaluate the impact of factors like PCV7 introduction on resistance patterns.

Main Methods:

  • Systematic review of studies published within the past 10 years.
  • Analysis of antibiotic resistance trends and serotype distribution.
  • Examination of factors influencing the prevalence of resistant SP serotypes.

Main Results:

  • Significant changes in antibiotic resistance and serotype distribution observed over the decade.
  • The introduction of PCV7 has influenced serotype prevalence and resistance patterns.
  • Multidrug-resistant serotype 19A has emerged as a particular concern.

Conclusions:

  • Antibiotic-resistant SP is a critical global health issue.
  • Effective strategies include vaccination programs, antibiotic stewardship, and continuous surveillance.
  • Addressing multidrug-resistant strains like 19A is essential for public health protection.

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...